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ABSTRACT
Airway stem cells slowly self-renew and produce differentiated
progeny to maintain homeostasis throughout the lifespan of an
individual. Mutations in the molecular regulators of these processes
may drive cancer or degenerative disease, but are also potential
therapeutic targets. Conditionally deleting one copy of FGF receptor 2
(FGFR2) in adult mouse airway basal cells results in self-renewal and
differentiation phenotypes.We show that FGFR2 signalling correlates
with maintenance of expression of a key transcription factor for basal
cell self-renewal and differentiation: SOX2. This heterozygous
phenotype illustrates that subtle changes in receptor tyrosine
kinase signalling can have significant effects, perhaps providing an
explanation for the numerous changes seen in cancer.
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INTRODUCTION
Like human airways, the mouse trachea contains three major
epithelial lineages (Rock et al., 2010; Teixeira et al., 2013). Basal
cells (BCs) are a stem cell population and include slowly dividing
stem cells and committed luminal precursors (Mori et al., 2015; Rock
et al., 2009; Watson et al., 2015). Luminal secretory cells self-renew
and produce terminally differentiated ciliated cells (Rawlins and
Hogan, 2008; Rawlins et al., 2007, 2009). Multiple studies have
shown that SOX2 is a key transcription factor (TF) for the
development and maintenance of all airway epithelial cells (Gontan
et al., 2008; Hashimoto et al., 2012; Ochieng et al., 2014; Que et al.,
2009; Tompkins et al., 2009, 2011). Deletion of Sox2 in adult mouse
tracheal epithelium caused loss of differentiated cells. Moreover, the
Sox2Δ/Δ BCs were less able to proliferate in vitro or in vivo following
injury (Que et al., 2009). SOX2 is thus required for BC self-renewal
and luminal differentiation. SOX2 overexpression can be a driver of
squamous cell carcinoma, which has a predominantly basal cell
phenotype (Correia et al., 2017; Ferone et al., 2016).
FGFR2 function has been extensively studied during lung
branching where one of its roles is to maintain undifferentiated
epithelial progenitors by inhibiting SOX2 expression (Abler et al.,
2009; Que et al., 2007; Volckaert et al., 2013). However, at later
stages of embryonic development ectopic FGF10 can promote BC
differentiation in SOX2+ airway progenitors (Volckaert et al.,
2013). The same study expressed a secreted dominant-negative
FGFR2 in the late stages of embryogenesis and suggested that there
could be a role for FGFR2 signalling in maintenance of airway BCs.
We have now specifically tested this hypothesis in the steady-state
adult mouse trachea, and show that FGFR2 is required for BC self-
renewal and terminal differentiation. Moreover, FGFR2 signalling
maintains SOX2 expression.
RESULTS AND DISCUSSION
FGFR2 is required for normal tracheal homeostasis
We detected FGFR2 protein in airway basal cells and at the apical
surface of secretory cells (Fig. 1A,B), confirming previous results
(Watson et al., 2015). To determine the role of FGFR2 in BCs, we
conditionally deleted one copy of Fgfr2 and activated a GFP
reporter in adult tracheal BCs using Tg(KRT5-CreER);
Rosa26RfGFP/+; Fgfr2fx/+ (Fgfr2 conditional heterozygous, cHet)
and control Tg(KRT5-CreER); Rosa26RfGFP/+ mice (Fig. 1C). To
test for co-recombination between Fgfr2fx and the reporter, we
isolated GFP+ BCs by flow cytometry as GFP+, GSIβ4-lectin+ cells
at 3 weeks post-tamoxifen (tmx) induction and performed RT-
qPCR for Fgfr2 (Fig. 1D). This confirmed that cHet BCs had ∼50%
of the control Fgfr2 mRNA level. Hence, we use GFP+ cells as a
surrogate marker for Fgfr2Δ/+ cells, being aware that co-
recombination will not be 100%. Tracheae were harvested at
intervals to assess the contribution of GFP+, Fgfr2Δ/+ BCs to the
epithelium during homeostatic turnover (Fig. 1E). At 1.5 weeks
post-tmx, ∼30% of total BCs were GFP+ in Fgfr2cHet and control
mice. In controls, this percentage increased to ∼60% at 5 weeks
post-tmx, before dropping to initial levels by 24 weeks. By contrast,
in the Fgfr2cHet tracheae, the percentage of GFP+ BCs remained
approximately constant at 5 weeks, but decreased to less than 5% of
total basal cells by 24 weeks (Fig. 1F). In both genotypes, labelled
BCs produced labelled luminal cells. Luminal differentiation
initially appeared more rapid in the Fgfr2cHets. However, luminal
cell production was not sustained over time, likely due to the loss of
GFP+ BCs, and by 24 weeks the percentage of labelled luminal cells
was significantly lower in the Fgfr2cHet tracheae (Fig. 1G).
This showed that Fgfr2cHet BCs can produce luminal cells, but
that mutant basal and luminal cells are gradually lost. One possible
reason for the loss of Fgfr2cHet cells is differential fitness and
competition with neighbouring wild-type cells (Vivarelli et al.,
2012). To test this, wemixed pure populations ofRosa26RtdTomato/+;
Fgfr2Δ/+with unlabelled Fgfr2+/+BCs (1:2 ratio) and assessed their
ability to compete in vitro at steady-state and following injury. We
were unable to find evidence for differential proliferation or survival
in the mixed cultures and conclude that it is unlikely that cell
competition contributes to the observed loss ofmutant cells (Fig. S1;
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Fgfr2cHet BCs do not differentiate into fully mature luminal
cells
We asked whether the loss of Fgfr2cHet cells was due to a decrease
in cell division. As expected, proliferation rates were low in all
tracheae, but dividing GFP+ cells were observed (Fig. S2A). We
noted an increase in proliferation of the Fgfr2cHet GFP+ cells at
1.5 weeks post-tmx, although this was not statistically significant
and the changewas not sustained over time (Fig. S2B). Thus, altered
proliferation does not explain the phenotype. We also assessed
apoptosis using cleaved caspase 3 staining, but did not identify
caspase 3+ cells (665 GFP+ cells scored in four independent 5 week
samples; Fig. S2C,D).
Fig. 1. Decreasing Fgfr2 levels in basal cells results in altered tracheal homeostasis. (A,B) Adult tracheal sections. (A) Green, FGFR2; red, T1α (basal cells).
(B) Green, FGFR2; red, SCGB1A1 (secretory cells). FGFR2+ secretory cells (arrowheads); rare SCGB1A1+, FGFR2− cells (arrow). (C) Experimental schematic.
(D) Relative expression of Fgfr2 mRNA in GFP+ basal cells from control and Fgfr2cHet mice 3 weeks post-tmx. (E) Representative sections from control
Tg(KRT5-CreER); Rosa26RfGFP/+ and cHet Tg(KRT5-CreER); Rosa26RfGFP/+; Fgfr2fx/+ tracheae. Green, GFP (Rosa reporter); red, T1α (basal cells).
Arrowheads indicate GFP+ basal cells. (F,G) Percentage of the total T1α+ BCs that are also GFP+ (F) and percentage of the total T1α− luminal cells that are also
GFP+ (G). Blue, DAPI. Error bars indicate s.e.m. Scale bars: 50 μm.
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We assessed the ability of Fgfr2cHet cells to differentiate by
analysing the luminal (KRT8) and basal (KRT5) cytokeratins at
5 weeks post-tmx (Fig. 2A). A higher percentage of the total GFP+
cells co-stained with KRT8 in the mutants, indicating that more cells
had begun differentiation to a luminal fate (Fig. 2B). Similarly,
plotting the GFP/T1α staining (Fig. 1D) as a percentage of GFP+
cells (GFP+, T1α−) showed more differentiating cells in the mutants
(Fig. 2B). Thus, Fgfr2cHet cells exit the basal layer at a greater rate
than controls and their descendants take on a luminal KRT8+, T1α−
fate, suggesting a self-renewal defect.
At steady-state, BCs initially differentiate into secretory cells that
later produce ciliated cells (Watson et al., 2015). Cell fate analysis at
5 weeks post-tmx showed that both control andFgfr2cHetBCsproduce
secretory SCGB1A1+ cells (Fig. 2C,D). Moreover, there were no signs
of goblet cell production in themutants (Fig. 2C; n=4MUC5AClo cells
observed from859 cells counted in 5Fgfr2cHet individuals). However,
analysis of acetylated tubulin-positive cilia (marker of terminal luminal
differentiation) at 24 weeks post-tmx showed that the Fgfr2cHet cells
never took on a ciliated cell identity (Fig. 2E).
Fgfr2cHet BCs have high levels of β-galactosidase activity
in vitro
We tested the ability ofFgfr2cHet cells to proliferate and differentiate
in vitro using a high dose of an adenovirus containing CMV-Cre
(Ad-Cre) to recombine Rosa26RfGFP/+; Fgfr2fx/+ and control
Rosa26RfGFP/fGFP BCs grown in self-renewing conditions
Fig. 2. Fgfr2 conditional heterozygous basal cells do not produce terminally differentiated luminal cells. (A) Confocal projections from control and Fgfr2cHet
tracheae 5 weeks post-tmx. Green, GFP (Rosa reporter); red, KRT5 (basal cells); white, KRT8 (luminal cells); blue, DAPI (nuclei). Arrowheads indicate GFP+ luminal
cells. Arrows indicate GFP+ basal cells. (B) Percentage of all GFP+ cells 5 weeks post-tmx that are GFP+, T1 α− (see Fig. 1D) or GFP+, KRT8+ (see A). (C) Sections
fromcontrol andFgfr2cHet tracheae 5 weeks post-tmx.Green, GFP (Rosa reporter); red, SCGB1A1 (club cells); white,MUC5AC (mucous). Arrows indicate club cells
containing a low level of MUC5ACprotein. (D) Percentage of all GFP+ cells 5 weeks post-tmx that areGFP+, SCGB1A1+. (E) Confocal sections from control andFgfr2
cHet tracheae at 24 weeks post-tmx. Green, GFP (Rosa reporter); red, acetylated tubulin (cilia). Error bars indicate s.e.m. Scale bars: 20 μm in A,C; 25 μm in E.
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(Fig. 3A). When analysed by genomic PCR, this resulted in an
almost-pure population of Fgfr2Δ/+ cells (Fig. S3A,B). Four days
after Ad-Cre-mediated deletion, we observed an increased proportion
of KRT8+ cells in the Fgfr2cHet cultures (Fig. 3A-C). This
recapitulates the in vivo phenotype and supports the conclusion that
Fgfr2cHet BCs have a self-renewal defect. Additional cultures were
Fig. 3. Fgfr2 conditional heterozygous basal cells have high levels of β-galactosidase and low levels of SOX2. (A) Experimental schematic for B-G.
(B) Percentage tracheal epithelial cells at day 6 post-seeding expressing KRT5 and/or KRT8. (C,D) Control and Fgfr2cHet tracheal cells day 6 post-seeding.
(C) Green, KRT5 (basal cells); red, KRT8 (luminal cells). (D) X-gal assay for β-galactosidase activity (blue pigment). (E) Representativewestern blots from control
and Fgfr2cHet BCs. (F) Quantification of protein levels in E. (G) SOX2 in cHet BCs day 6 post-seeding. Green, E-cadherin (lateral cell membranes); red, SOX2.
(H,I) Confocal images of control and Fgfr2cHet tracheal sections 5 weeks post-tmx. Green, GFP (Rosa reporter); red, SOX2; magenta, FGFR2. White arrows
indicate lineage-labelled cells with decreased levels of SOX2. Arrowheads indicate lineage-labelled cells with no change in SOX2. Yellow arrows indicate
unlabelled cells with decreased SOX2. Brackets in I indicate a patch of GFP+ cells that have decreased FGFR2 and no SOX2. Blue, DAPI. Error bars indicate
s.e.m. Scale bars: 100 μm in C; 250 μm in D; 50 μm in G; 25 μm in H,I.
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passaged and grown to confluence before differentiation at air-liquid
interface (Fig. S4A-D). The Fgfr2cHet cells survived passaging but
did not reach confluence and failed to express markers of ciliated or
basal cell differentiation. Moreover, passaged cells were unable to
grow in sphere-forming assays (Fig. S4E-H). The passaged
Fgfr2cHet cells were somewhat enlarged and flattened, possibly
indicating a senescent phenotype (Rodier and Campisi, 2011). We
therefore tested for senescence-associated β-galactosidase activity in
primary cultures of Fgfr2cHet cells. β-Galactosidase activity was
detected in 3/3 Fgfr2cHet cultures and 0/3 controls (Fig. 3D).
Senescence of the Fgfr2cHet cells in vivo could potentially explain
why the luminal GFP+ cells can express secretorymarkers, but do not
later produce ciliated cells. However, we cannot absolutely exclude a
luminal fate choice defect in Fgfr2cHet BCs.
Lower levels of SOX2 expression in the Fgfr2 conditional
heterozygous cells
We determined the effects of decreasing FGFR2 signalling on
downstream pathways using immunoblotting. There was a 1.5-fold
decrease in phosphorylated AKT in the Fgfr2Δ/+ cells (Fig. 3E,F),
Fig. 4. FGF7 and FGF10 increase colony size of
wild-type basal cells. (A) Experimental
schematic. Epithelial cells plated at low density,
3×104 cells/insert. (B) Colonies formed by control,
FGF7- or FGF10-treated wild-type cells. Red,
E-cadherin; blue, DAPI. Scale bar: 100 μm.
(C) Number of cells per colony in B. Data are
mean±s.e.m. (D) Level of Sox2 mRNA relative to
control (normalized to 1) in cells treated with FGF7
or FGF10 for 1 or 2 days. Error bars indicate
s.e.m. (E) Fgfr2cHet BCs rarely make self-
renewing divisions in which a newBC is produced.
Mutant BCs are more likely to produce
descendants with luminal morphology/markers
that are unable to completely differentiate,
possibly because they senesce. The result is that
GFP+ Fgfr2cHet cells are gradually diluted out
from both the basal and luminal populations, and
the epithelium is sustained by GFP− wild-type
BCs.
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but no change in phosphorylated ERK1/2 (Fig. S3C,D). These
changes are consistent with a decrease in FGFR2 signalling via the
PI3K-AKT pathway, which was implicated as the main pathway
downstream of FGFR2 in adult small airway secretory cells and the
developing trachea (Volckaert et al., 2011, 2013).
Most strikingly, there was a twofold decrease in SOX2 in the
Fgfr2Δ/+ cells (Fig. 3E,F; Fig. S3C,D). We confirmed the decrease
in SOX2 protein at a cellular level by in vitro immunostaining
(Fig. 3G). Similarly, there was consistently lower SOX2 expression
in GFP+ cells in the Fgfr2cHet tracheae in vivo (Fig. 3H, arrows). As
expected from the genetic strategy, in the mutants we also observed
GFP+, SOX2+ cells (Fig. 3H, arrowheads) and GFP−, SOX2− cells
(Fig. 3H, yellow arrows), both are likely to have recombined only
one floxed allele. Co-immunostaining with FGFR2 confirmed that
the GFP+, SOX2+ cells observed in the mutants retained high levels
of FGFR2 protein (Fig. 3I).
FGF7 and FGF10 can promote BC colony expansion in vitro
We predicted that if a decrease in Fgfr2 results in loss of BC
self-renewal, then activation of FGFR2 in vitro should promote the
growth of BC colonies. FGF7 and FGF10 are expressed in
homeostatic tracheae (Balasooriya et al., 2016) and are known to
activate FGFR2 preferentially in vitro and in vivo (Ornitz et al., 1996).
We plated wild-type BCs at low density and added FGF7 or FGF10
on culture day 2 after colonies were established (Fig. 4A). Addition of
FGF7 or FGF10 had the opposite effect to decreasing Fgfr2 and
significantly increased colony size (Fig. 4B,C). Interestingly, FGF7
and FGF10 had no effect on the level of Sox2 mRNA (Fig. 4D).
In conclusion, our data suggest that a normal function of FGFR2
signalling in adult airway BCs is to promote asymmetric self-
renewing divisions (Fig. 4E). This is consistent with work in the
embryonic trachea where ectopic FGF10 was observed to promote
BC fate (Volckaert et al., 2013). By contrast, our previous work on
FGFR1 in adult BCs showed that FGFR1 is required to inhibit
steady-state proliferation and does not change the ability of BCs to
self-renew (Balasooriya et al., 2016). Thus, FGFR1 and FGFR2
have independent functions in airway BCs. We cannot exclude the
possibility that they also have other overlapping functions.
We also show that steady-state FGFR2 signalling is required,
directly or indirectly, to maintain SOX2 protein levels in the adult
airway. This is in contrast to the branching lung, where FGFR2
inhibits SOX2 expression at the tips. Interestingly, an FGFR2-
SOX2 inductive relationship has been observed in other cell types
(Mansukhani et al., 2005). An FGFR2-SOX2 relationship may be
maintained in some squamous lung cancers where FGFR2 and
SOX2 transcript levels are often correlated (Kim et al., 2016).
Haploinsufficiency of Fgfr2 in conditionally deleted adult
cells
We were surprised that our Fgfr2cHet BCs displayed striking
phenotypes when germline Fgfr2Δ/+ animals are viable and fertile
(Yu et al., 2003). We therefore looked for subtle epithelial defects in
germline-deleted Fgfr2Δ/+ tracheae compared with wild-type
siblings, but were unable to find any abnormalities (Fig. S5).
Fgfr2 is haploinsufficient in several organs, including the lacrimal
and salivary glands (Shams et al., 2007). We suggest that in mouse
embryos heterozygous for Fgfr2, genetic compensation operates in
most tissues. However, conditional heterozygous deletion in the
adult by-passes such mechanisms. This is very similar to recent
findings from zebrafish genetics where genetic compensation has
been found to operate in germline mutants, but not in acute
knockdowns (Rossi et al., 2015). It raises the possibility that many
genes that the mouse developmental community assume are
uninteresting/redundant based on lack of germline knockout
phenotypes do play important roles in development/homeostasis.
MATERIALS AND METHODS
Mice
Experimentswere approvedby local ethical review committees and conducted
according to UK Home Office project licenses PPL80/2326 and 70/812.
Fgfr2fx (Yu et al., 2003), Tg(KRT5-CreER) (Rock et al., 2009), Rosa26R-
fGFP (Rawlins et al., 2009), Gt(ROSA)26Sortm1(CAG-tdTomato*,-EGFP*)Ees
(Prigge et al., 2013) and Fgfr2Δ/+ animals were generated by crossing
Fgfr2fx toZp3-Cre (deVries et al., 2000). The genetic backgroundwasC57Bl/
6J.Males and females >8 weeks oldwere used. Thewild typeswereC57Bl/6J.
Tamoxifen
Adult (>8 week) animals were injected intraperitoneally four times, every
other day, with 0.2 mg/g body weight tamoxifen.
Tracheal epithelial cell culture
Tracheal cells were isolated following published methods (Rock et al.,
2009). Briefly, cells were incubated in Dispase II (Gibco, 16 U/ml) for
20 min at room temperature. Epithelial sheets were dissociated using 0.1%
trypsin/EDTA. Unless otherwise stated, 5×104 cells in 0.5 ml MTEC/+
media (You et al., 2002) were plated on collagen-coated 12-well tissue
culture inserts (BD Falcon, 353180). For tracheospheres, cells were
passaged into 50% matrigel (Becton Dickinson). Adeno-Cre (University
of Iowa, Gene Transfer Vector Core) was incubated at MOI 2500; vector pfu
1×106 for 8 h. Recombinant mouse FGF7 and FGF10 (R&D Systems) were
used at 100 ng/ml. For competition assays, mixed populations of cells were
grown to confluence and then imaged every 4 h for 10 days in a Nikon
Biostation. Alternatively, confluent cultures were scratched and imaged
every 2 h for 5 days. In vitro experiments were preformed in triplicate.
Immunostaining
Tracheae were fixed in 4% paraformaldehyde at 4°C for 4 h; washed PBS,
sucrose protected, embedded in OCT (Optimum Cutting Temperature
Compound, Tissue Tek) and sectioned at 6 μm. Airway culture inserts were
washed in PBS, fixed for 10 min in 4% paraformaldehyde at room
temperature and permeabilized with 0.3% Triton X-100. Primary antibodies
are listed in Table S1. Alexa Fluor-conjugated secondary antibodies
(1:2000) were from Life Technologies (Table S1). DAPI and fluoromount
were from Sigma. X-gal staining was performed using Senescence β-
galactosidase staining kit (Cell Signaling, 9860).
Microscopy and image scoring
Slides were imaged on a Zeiss AxioImager compound, or a Leica Sp8/Sp5
confocal microscope. Cells were scored manually in Fiji. For cryosections,
every epithelial cell along the entire proximal to distal length of a
longitudinal section from the centre of the trachea was scored. For cultured
cells at least three random fields of view from each insert were scored. Raw
cell counts are available in Fig. S6.
RT-qPCR
Primary tracheal epithelial cells were isolated and sorted using a
fluorescence-activated cell sorting MoFlo flow cytometer. GFP+ basal cells
from control and Fgfr2cHet tracheae were sorted as GFP+, GSIβ4 lectin+
(Balasooriya et al., 2016). Total RNA was extracted using Qiagen RNEasy
Mini Kit. Taqman gene expression assays for Ppia (Mm02342429_g1),
Fgfr2 (Mm01269930_m1) and Sox2 (Mm03053810_s1) (Life
Technologies) were used.
Immunoblots
Cells were collected in Cell Extraction Buffer (Invitrogen, FNN0011) with
protease inhibitor (Roche 04693116001) and PMSF (Sigma, P7626).
Proteins were separated on 10% or 12% SDS-PAGE gels before being
transfer onto Millipore Immobilon-P PVDF Membrane (Merck Millipore,
IPVH00010). Primary antibodies are listed in Table S1. Detection with
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HRP-conjugated secondaries (Abcam, 1:10,000) and enhanced
chemiluminescense (Thermo Scientific, PI-32109) was carried out.
Quantitation is based on protein from three biological replicates separated
on the same polyacrylamide gel. Band intensity was analysed in Fiji
normalised to the loading control.
Statistics
P-values were obtained using an unpaired two-tailed student’s t-test with
unequal variance.
Acknowledgements
We thank Quitz Jeng and Jane Brady for technical assistance.
Competing interests
The authors declare no competing or financial interests.
Author contributions
G.I.B. designed and performed experiments, analysed data and edited the
manuscript. M.G. designed, performed and analysed experiments. E.P. designed
experiments and edited the manuscript. E.L.R. conceived and led the project,
designed and performed experiments, analysed data, and wrote and edited the
manuscript.
Funding
This study was supported by the Medical Research Council (G0900424 to E.R.).
Core funders were as follows: Wellcome Trust (092096) and Cancer Research UK
(C6946/A14492) supporting the Gurdon Institute; Wellcome Trust and Medical
Research Council supporting the Stem Cell Initiative. Deposited in PMC for
immediate release.
Supplementary information
Supplementary information available online at
http://dev.biologists.org/lookup/doi/10.1242/dev.135681.supplemental
References
Abler, L. L., Mansour, S. L. and Sun, X. (2009). Conditional gene inactivation
reveals roles for Fgf10 and Fgfr2 in establishing a normal pattern of epithelial
branching in the mouse lung. Dev. Dyn. 238, 1999-2013.
Balasooriya, G. I., Johnson, J.-A., Basson, M. A. and Rawlins, E. L. (2016). An
FGFR1-SPRY2 signaling axis limits basal cell proliferation in the steady-state
airway epithelium. Dev. Cell 37, 85-97.
Correia, L. L., Johnson, J. A., McErlean, P., Bauer, J., Farah, H., Rassl, D. M.,
Rintoul, R. C., Sethi, T., Lavender, P., Rawlins, E. L. et al. (2017). SOX2 drives
bronchial dysplasia in a novel organotypic model of early human squamous lung
cancer. Am. J. Respir. Crit. Care. Med. doi:10.1164/rccm.201510-2084OC.
de Vries, W. N., Binns, L. T., Fancher, K. S., Dean, J., Moore, R., Kemler, R. and
Knowles, B. B. (2000). Expression of Cre recombinase in mouse oocytes: a
means to study maternal effect genes. Genesis 26, 110-112.
Ferone, G., Song, J.-Y., Sutherland, K. D., Bhaskaran, R., Monkhorst, K.,
Lambooij, J.-P., Proost, N., Gargiulo, G. and Berns, A. (2016). SOX2 is the
determining oncogenic switch in promoting lung squamous cell carcinoma from
different cells of origin. Cancer Cell 30, 519-532.
Gontan, C., de Munck, A., Vermeij, M., Grosveld, F., Tibboel, D. and Rottier, R.
(2008). Sox2 is important for two crucial processes in lung development:
branching morphogenesis and epithelial cell differentiation. Dev. Biol. 317,
296-309.
Hashimoto, S., Chen, H., Que, J., Brockway, B. L., Drake, J. A., Snyder, J. C.,
Randell, S. H. and Stripp, B. R. (2012). beta-Catenin-SOX2 signaling regulates
the fate of developing airway epithelium. J. Cell Sci. 125, 932-942.
Kim, B. R., Van de Laar, E., Cabanero, M., Tarumi, S., Hasenoeder, S., Wang, D.,
Virtanen, C., Suzuki, T., Bandarchi, B., Sakashita, S. et al. (2016). SOX2 and
PI3K cooperate to induce and stabilize a squamous-committed stem cell injury
state during lung squamous cell carcinoma pathogenesis. PLoS Biol. 14,
e1002581.
Mansukhani, A., Ambrosetti, D., Holmes, G., Cornivelli, L. and Basilico, C.
(2005). Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt
signaling and osteoblast differentiation. J. Cell Biol. 168, 1065-1076.
Mori, M., Mahoney, J. E., Stupnikov, M. R., Paez-Cortez, J. R., Szymaniak, A. D.,
Varelas, X., Herrick, D. B., Schwob, J., Zhang, H. and Cardoso, W. V. (2015).
Notch3-Jagged signaling controls the pool of undifferentiated airway progenitors.
Development 142, 258-267.
Ochieng, J. K., Schilders, K., Kool, H., Boerema-De Munck, A., Buscop-Van
Kempen, M., Gontan, C., Smits, R., Grosveld, F. G., Wijnen, R. M., Tibboel, D.
et al. (2014). Sox2 regulates the emergence of lung basal cells by directly
activating the transcription of Trp63. Am. J. Respir. Cell Mol. Biol. 51, 311-322.
Ornitz, D. M., Xu, J., Colvin, J. S., McEwen, D. G., MacArthur, C. A., Coulier, F.,
Gao, G. and Goldfarb, M. (1996). Receptor specificity of the fibroblast growth
factor family. J. Biol. Chem. 271, 15292-15297.
Prigge, J. R., Wiley, J. A., Talago, E. A., Young, E. M., Johns, L. L., Kundert,
J. A., Sonsteng, K. M., Halford, W. P., Capecchi, M. R. and Schmidt, E. E.
(2013). Nuclear double-fluorescent reporter for in vivo and ex vivo analyses of
biological transitions in mouse nuclei. Mamm. Genome 24, 389-399.
Que, J., Okubo, T., Goldenring, J. R., Nam, K.-T., Kurotani, R., Morrisey, E. E.,
Taranova, O., Pevny, L. H. andHogan, B. L. M. (2007). Multiple dose-dependent
roles for Sox2 in the patterning and differentiation of anterior foregut endoderm.
Development 134, 2521-2531.
Que, J., Luo, X., Schwartz, R. J. and Hogan, B. L. M. (2009). Multiple roles for
Sox2 in the developing and adult mouse trachea. Development 136, 1899-1907.
Rawlins, E. L. and Hogan, B. L. M. (2008). Ciliated epithelial cell lifespan in the
mouse trachea and lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 295, L231-L234.
Rawlins, E. L., Ostrowski, L. E., Randell, S. H. and Hogan, B. L. M. (2007). Lung
development and repair: contribution of the ciliated lineage. Proc. Natl. Acad. Sci.
USA 104, 410-417.
Rawlins, E. L., Okubo, T., Xue, Y., Brass, D. M., Auten, R. L., Hasegawa, H.,
Wang, F. and Hogan, B. L. M. (2009). The role of Scgb1a1+ Clara cells in the
long-termmaintenance and repair of lung airway, but not alveolar, epithelium.Cell
Stem Cell 4, 525-534.
Rock, J. R., Onaitis, M. W., Rawlins, E. L., Lu, Y., Clark, C. P., Xue, Y., Randell,
S. H. and Hogan, B. L. M. (2009). Basal cells as stem cells of the mouse trachea
and human airway epithelium. Proc. Natl. Acad. Sci. USA 106, 12771-12775.
Rock, J. R., Randell, S. H. and Hogan, B. L. M. (2010). Airway basal stem cells: a
perspective on their roles in epithelial homeostasis and remodeling. Dis. Model.
Mech. 3, 545-556.
Rodier, F. and Campisi, J. (2011). Four faces of cellular senescence. J. Cell Biol.
192, 547-556.
Rossi, A., Kontarakis, Z., Gerri, C., Nolte, H., Hölper, S., Krüger, M. and Stainier,
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